Market ExpansionFemaSeed is now being offered in more than 60 clinics across the U.S., which could allow for quick patient access.
PartnershipsStrategic distribution partnerships in Spain are set to drive the initial FemBloc launch, with additional EU partnerships expected soon.
Regulatory ApprovalFemBloc system receives EU approval, clearing it for commercial launch in select markets, starting with Spain.